Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Zero Based Budgeting introduces core planning principles: enumerate needs, allocate from zero, and reassess periodically to stay aligned with long-term aims.
22,602 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
CoreWeave stock tumbling today underscores the volatility in AI infrastructure plays. This explainer breaks down what...
Venice AI closes a $65 million Series A led by Dragonfly at a $1 billion valuation, funding growth with equity. The m...
The 2008 crisis left more than scars. Its real legacy 2008: moral hazard and policy backstops still push risk, pricin...
Two healthcare ETFs offer very different paths for investors: a broad, low-cost core and a concentrated pharmaceutica...
XRP surged above key resistance as volume inflows and ETF demand point to renewed institutional interest. Regulators ...
Oil markets roiled by Hormuz disruptions push energy ETFs past the 50% mark for the year, prompting a closer look at ...
J.P. Morgan updates its U.S. Analyst Focus List for July, spotlighting a dependable dividend payer. The move comes as...
CoreWeave rode the AI compute wave, but headwinds have grown. This guide explains what's wrong with CoreWeave, the co...
London-based Fleek lands $25 million in a Series B to grow its network of vintage wholesalers and U.S./EU retailers. ...
Occidental Petroleum climbs on an Evercore upgrade and a stronger oil backdrop, outpacing ExxonMobil and Chevron as t...
A hedge-fund short report rattled Bloom Energy, triggering a brief stock drop before a swift rebound. Investors are w...